A Clinical trial to study the effects and economical efficiency of two drugs, Teneligliptin and Glimepiride in patients with poor control of Type2 Diabetes mellitus by metformin drug.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2021/05/033634
- Lead Sponsor
- Dr V Gayathri
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.AGE between 30 to 60 years.
2.Both male and female.
3.Clinically diagnosed with Type2DM.
4.Poor glycemic control by Metformin monotherapy with HbA1c > 7.5
Exclusion Criteria
1.Type 1 diabetes mellitus.
2.Patients already on treatment with two or more Oral Hypoglycemic Agents.
3.Pregnancy and Lactation.
4.History of Alcohol intake and smoking.
5.History of renal and hepatic disorders.
6.Allergy to Teneligliptin and Glimepiride.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method significant reduction of HbA1C value after treatment and ICER analysisTimepoint: 12 week
- Secondary Outcome Measures
Name Time Method side effects if anyTimepoint: 12 week